Amid all the shocking and depressing news regarding the future of American healthcare and medicine, at least over the next ...

Delcath's Q3 sales hit $10 million, unlocking $25 million for Phase 2 trials. Click here to find out my analysis of DCTH ...

Learn more about the car you're interested in before you buy. Not quite sure where to start? Explore models that fit your needs. See all of the winners and nominees. Winner Nominee Nominee Nominee ...

DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...

Merck & Co. Inc.'s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer drug Keytruda. Rahway, N.J.-based Merck (MRK) said a trial of the drug, given ...

Researchers at Children's Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene therapy ...

Research programme: Celiac disease, and others are under different phases of Celiac Disease clinical trials. In October 2024, Topas Therapeutics announced positive topline results from its Phase IIa ...

After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

As Global Head of Oncology for IQVIA Biotech, Gerhard du Toit manages all aspects of oncology clinical trials, optimising ...

Patients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are ...